Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman's health, and general practice services. In addition, the company's services include consultation, medical diagnosis, and medical and surgical treatments. Basel Medical Group Ltd was incorporated in 2023 and is headquartered in Singapore.…
Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering
Basel Medical Group (NASDAQ: BMGL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 74 employees.
The shares were at 0.3832 USD on 20 November 2026, down 97.2% over 52 weeks. Its 52-week range is 0.2475 USD to 15.24 USD: the price is 97.5% below the high and 54.8% above the low.
Its market capitalisation is 5.20M USD.
Basel Medical Group reports return on equity of -14.8%, an operating margin of -8.3% and revenue up 91.3% year over year.
Its debt exceeds its cash by 1.73M SGD, a debt-to-equity ratio of 1.71. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.